Home › Dementia

Dementia clinical trials recruiting in the U.S.

135 studies for Dementia are recruiting participants at sites across the United States.

People with dementia have serious problems with two or more brain functions, such as memory and language. Affects the ability to do normal activities.

Cities with the most studies

• New York City, NY12 studies
• Los Angeles, CA12 studies
• Chicago, IL10 studies
• Miami, FL9 studies
• Tampa, FL9 studies
• Baltimore, MD9 studies
• St. Louis, MO9 studies
• Orlando, FL8 studies
• San Diego, CA8 studies
• Indianapolis, IN8 studies
• Boston, MA8 studies
• Durham, NC8 studies
• Atlanta, GA8 studies
• San Antonio, TX7 studies
• Austin, TX7 studies
• Phoenix, AZ7 studies
• Providence, RI7 studies
• Portland, OR7 studies
• The Villages, FL6 studies
• Columbus, OH6 studies
• Seattle, WA6 studies
• Charlotte, NC5 studies
• Long Beach, CA5 studies
• Houston, TX5 studies
• West Palm Beach, FL5 studies
• Birmingham, AL5 studies
• Dallas, TX5 studies
• Philadelphia, PA5 studies
• Pittsburgh, PA5 studies
• Nashville, TN5 studies
• San Francisco, CA5 studies
• Dayton, OH4 studies
• Las Vegas, NV4 studies
• Irvine, CA4 studies
• New Haven, CT4 studies
• Gainesville, FL4 studies
• Jacksonville, FL3 studies
• Hollywood, FL3 studies
• Newton, MA3 studies
• Melbourne, FL3 studies

By state

• Alabama5 studies
• Arizona10 studies
• California29 studies
• Colorado9 studies
• Connecticut5 studies
• Florida27 studies
• Georgia11 studies
• Illinois13 studies
• Indiana10 studies
• Iowa3 studies
• Kansas3 studies
• Louisiana3 studies
• Maryland10 studies
• Massachusetts17 studies
• Michigan4 studies
• Minnesota3 studies
• Missouri12 studies
• Nevada4 studies
• New Jersey8 studies
• New York18 studies
• North Carolina13 studies
• Ohio10 studies
• Oregon8 studies
• Pennsylvania10 studies
• Rhode Island7 studies
• Tennessee8 studies
• Texas20 studies
• Utah4 studies
• Virginia8 studies
• Washington8 studies
• Wisconsin3 studies

Recently updated studies

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.